Skip to main content

Year: 2019

La-Z-Boy Reports Fiscal 2020 Second-Quarter Results

MONROE, Mich., Nov. 20, 2019 (GLOBE NEWSWIRE) — La-Z-Boy Incorporated (NYSE: LZB) today reported its operating results for the fiscal 2020 second quarter ended October 26, 2019.Fiscal 2020 second quarter versus Fiscal 2019 second quarter:Consolidated sales for the second quarter increased 1.8% to $447.2 millionLa-Z-Boy Furniture Galleries® stores:Written same-store sales for the La-Z-Boy Furniture Galleries® network increased 3.5%Delivered same-store sales for the company-owned Retail segment increased 5.0%Consolidated operating margin:GAAP: 6.6% versus 6.5%Non-GAAP*: 7.5% versus 7.3%Net income attributable to La-Z-Boy Incorporated per diluted share (“EPS”):GAAP:  $0.48 versus $0.42Non-GAAP*: $0.52 versus $0.48Fiscal 2020 excludes a $0.03 charge for purchase accounting, a $0.04 charge related to the company’s supply chain optimization...

Continue reading

Health Catalyst to Participate in Upcoming Investor Conferences

SALT LAKE CITY, Nov. 20, 2019 (GLOBE NEWSWIRE) — Health Catalyst, Inc. (“Health Catalyst”, Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced that Patrick Nelli, Chief Financial Officer, and Adam Brown, Senior Vice President, Investor Relations, will participate in the following upcoming investor conferences.Piper Jaffray 31st Annual Healthcare Conference in New York on Wednesday, December 4, 2019, which will include a presentation at 9:30 a.m. ET.Evercore ISI 2nd Annual HealthCONx Conference in Boston on Thursday, December 5, 2019, which will include a presentation at 11:00 a.m. ET.About Health CatalystHealth Catalyst is a leading provider of data and analytics technology and services to healthcare organizations, committed to being the catalyst...

Continue reading

Inspire Medical Systems, Inc. to Present at the 31st Annual Piper Jaffray Healthcare Conference

MINNEAPOLIS, Nov. 20, 2019 (GLOBE NEWSWIRE) — Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative and minimally invasive solutions for patients with obstructive sleep apnea, announced today that its management team will be presenting at the 31st Annual Piper Jaffray Healthcare Conference on December 4, 2019 at the Lotte New York Palace Hotel in New York.Inspire is scheduled to present at 8:30 a.m. Eastern Time. The presentation will be accessible via a live webcast at: https://event.webcasts.com/starthere.jsp?ei=1270355&tp_key=b1d62da24aA webcast replay of the presentation will be available for two weeks following the presentation in the Event Archive section of Inspire’s Investor website at https://investors.inspiresleep.com.About...

Continue reading

Domo to Demonstrate Solutions that Help Customers Drive Business Value from IoT Data at AWS re:Invent 2019

SILICON SLOPES, Utah, Nov. 20, 2019 (GLOBE NEWSWIRE) — Domo (Nasdaq: DOMO) today announced it will showcase at AWS re:Invent 2019 how customers can quickly, easily and securely deliver business value from their Internet of Things (IoT) data while maximizing the value of their Amazon Web Services (AWS) investments.Domo will highlight the capabilities of its recently announced Domo for AWS solution, a purpose-built package that gives AWS customers an easy way to make data from nearly two dozen AWS services securely accessible to virtually anyone across the company. Domo will also showcase its IoT Cloud, which features one of the largest sets of pre-built API connectors for IoT data, including AWS IoT Analytics, AWS IoT Core, AWS IoT Device Defender, AWS IoT Device Management, and Amazon Kinesis Data Streams. Domo’s IoT Cloud also...

Continue reading

Sportsman’s Warehouse Holdings, Inc. Announces Third Quarter Fiscal 2019 Earnings Conference Call

MIDVALE, Utah, Nov. 20, 2019 (GLOBE NEWSWIRE) — Sportsman’s Warehouse Holdings, Inc. (“Sportsman’s” or the “Company”) (Nasdaq: SPWH) today announced that it will hold its quarterly conference call to discuss third quarter fiscal 2019 financial results on Wednesday, December 4, 2019 at 4:30 p.m. Eastern Time. The conference call will be broadcast on the Company’s investor relations website at http://investors.sportsmans.com/.  An online archive of the webcast will be available for one year following the call.About Sportsman’s Warehouse Holdings, Inc.Sportsman’s Warehouse is an outdoor sporting goods retailer focused on meeting the everyday needs of the seasoned outdoor veteran, the first-time participant and every enthusiast in between. Our mission is to provide outstanding gear and...

Continue reading

PennantPark Floating Rate Capital Ltd. Announces Financial Results for the Fourth Quarter and Fiscal Year Ended September 30, 2019

NEW YORK, Nov. 20, 2019 (GLOBE NEWSWIRE) — PennantPark Floating Rate Capital Ltd. (NASDAQ: PFLT) (TASE: PFLT) announced today financial results for the fourth quarter and fiscal year ended September 30, 2019.CONFERENCE CALL AT 10:00 A.M. EST ON NOVEMBER 21, 2019PennantPark Floating Rate Capital Ltd. (“we,” “our,” “us” or the “Company”) will host a conference call at 10:00 a.m. (Eastern Standard Time) on Thursday, November 21, 2019 to discuss its financial results. All interested parties are welcome to participate. You can access the conference call by dialing toll-free (800) 263-0877 approximately 5-10 minutes prior to the call. International callers should dial (646) 828-8143. All callers should reference conference ID #9659175 or PennantPark Floating Rate Capital Ltd. An archived replay of the call will be available through December...

Continue reading

RTI Surgical® to Present at the 31st Annual Piper Jaffray Healthcare Conference in New York City

DEERFIELD, Ill., Nov. 20, 2019 (GLOBE NEWSWIRE) — RTI Surgical Holdings, Inc. (Nasdaq: RTIX), a global surgical implant company, today announced Camille Farhat, President and Chief Executive Officer, and Jonathon Singer, Chief Financial and Administrative Officer, are scheduled to present at the 31st Annual Piper Jaffray Healthcare Conference on Wednesday, December 4, at 11 a.m. EST in New York City.About RTI Surgical Holdings, Inc.RTI Surgical is a leading global surgical implant company providing surgeons with safe biologic, metal and synthetic implants. Committed to delivering a higher standard, RTI’s implants are used in sports medicine, general surgery, spine, orthopedic and trauma procedures and are distributed in nearly 50 countries. RTI has four manufacturing facilities throughout the U.S. and Europe. RTI is accredited in...

Continue reading

Enlivex Therapeutics Ltd. Announces Proposed Offering of Ordinary Shares

Nes Ziona, Israel, Nov. 20, 2019 (GLOBE NEWSWIRE) — Enlivex Therapeutics Ltd. (“Enlivex” or the “Company”) (NASDAQ:ENLV) today announced that, subject to market and other conditions, it intends to offer and sell ordinary shares (the “Shares”) in an underwritten public offering. The Company intends to grant the underwriter an option for a period of 45 days to purchase up to an additional 15 percent of the number of Shares to be issued and sold in the public offering solely to cover over-allotments, if any.The Company intends to use the net proceeds received from the offering of the Shares for clinical, regulatory, manufacturing and research and development activities, potential acquisitions and in-licensing, and other general corporate purposes.Aegis Capital Corp. will act as sole book-runner for the offering.The offering of the...

Continue reading

Diamondback Energy Prices Offering of Senior Notes

MIDLAND, Texas, Nov. 20, 2019 (GLOBE NEWSWIRE) — Diamondback Energy, Inc. (NASDAQ:FANG) (“Diamondback”) announced today that it has priced an offering of $1.0 billion of 2.875% senior notes that will mature on December 1, 2024 (“the 2024 notes”), $800 million of 3.250% senior notes that will mature on December 1, 2026 (“the 2026 notes”) and $1.2 billion of 3.500% senior notes that will mature on December 1, 2029 (“the 2029 notes” and, collectively with the 2024 notes and the 2026 notes, the “Notes”). The prices to the public for the 2024 notes, the 2026 notes and the 2029 notes are 99.959%, 99.858% and 99.741% of the principal amounts, respectively.Diamondback intends to use the net proceeds from the offering (i) to repay a portion of the outstanding borrowings under its revolving credit facility, (ii) to redeem all of the outstanding...

Continue reading

Pfenex to Present at the Piper Jaffray 31st Annual Healthcare Conference

SAN DIEGO, Nov. 20, 2019 (GLOBE NEWSWIRE) — Pfenex Inc. (NYSE American: PFNX) is a development and licensing biotechnology company focused on leveraging its Pfēnex Expression Technology® to develop and improve protein therapies for unmet patient needs. Using the patented Pfēnex Expression Technology platform, the Company has developed the FDA-approved PF708 product indicated for the treatment of osteoporosis in certain patients at high risk of fracture and created an advanced pipeline of therapeutic equivalents, biologics and vaccines. The Company announced today that Eef Schimmelpennink, President and Chief Executive Officer, will be presenting at the Piper Jaffray 31st Annual Healthcare Conference on Wednesday, December 4th, taking place at the Lotte New York Palace in New York.Piper Jaffray 31st Annual Healthcare ConferenceDate:               ...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.